Background: FAM83D is a spindle related protein and plays critical roles in mid-plate formation during mitosis. Aberrant FAM83D expression was reported in multiple cancers. Besides, it was observed that FAM83D was capable of promoting the proliferation and migration of normal or cancer cells in several tissues. Objective: we are aiming to update the latest advancement in FAM83D findings, and make a comprehensive review of FAM83D, in order to provide new perspectives for the research of FAM83D in tumors. Methods: Here, we summarized the latest published literatures of FAM83D in recent five years and categorized the research of FAM83D into lung cancer, digestive system cancers and female reproductive cancers. Then, we discussed the relationship of FAM83D and diagnosis, development and prognosis of multiple cancers, as well as the relevant in vitro intracellular underlying mechanisms. Conclusions: Up to now, FAM83D has been investigated in 9 types of cancers and its expression patterns found to tightly related to OS or DFS. Besides, most in vitro studies showed that FAM83D positively regulated cancer cell proliferations and differentiations. Furthermore, researches screened out several downstream targets and intracellular pathways of FAM83D as well as upstream regulatory factors. Prospectively, the biochemistry features of FAM83D protein and its potential as a biomarker of cancer diagnosis or therapy require more independent and rigorous studies.
| Published in | Biomedical Sciences (Volume 8, Issue 2) |
| DOI | 10.11648/j.bs.20220802.11 |
| Page(s) | 53-56 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
FAM83D, Malignant Tumors, Tumor Biomarkers
| [1] | Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, et al. The DNA sequence and comparative analysis of human chromosome 20. Nature. 2001 Dec 20-27; 414 (6866): 865-71. |
| [2] | Sauer G, Korner R, Hanisch A, Ries A, Nigg EA, Sillje HH. Proteome analysis of the human mitotic spindle. Mol Cell Proteomics. 2005 Jan; 4 (1): 35-43. |
| [3] | Santamaria A, Nagel S, Sillje HHW, Nigg EA. The spindle protein CHICA mediates localization of the chromokinesin Kid to the mitotic spindle. Curr Biol. 2008 May 20; 18 (10): 723-29. |
| [4] | Varisli L. Meta-analysis of the expression of the mitosis-related gene Fam83D. Oncol Lett. 2012 Dec; 4 (6): 1335-40. |
| [5] | Bartel CA, Parameswaran N, Cipriano R, Jackson MW. FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance. Oncotarget. 2016 Aug 9; 7 (32): 52597-612. |
| [6] | Shi R, Sun J, Sun Q, Zhang Q, Xia W, Dong G, et al. Upregulation of FAM83D promotes malignant phenotypes of lung adenocarcinoma by regulating cell cycle. Am J Cancer Res. 2016; 6 (11): 2587-98. |
| [7] | Yin C, Lin X, Wang Y, Liu X, Xiao Y, Liu J, et al. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer. Cell Oncol (Dordr). 2020 Jun; 43 (3): 395-407. |
| [8] | Yu C, Cheng Z, Cui S, Mao X, Li B, Fu Y, et al. circFOXM1 promotes proliferation of non-small cell lung carcinoma cells by acting as a ceRNA to upregulate FAM83D. J Exp Clin Cancer Res. 2020 Mar 30; 39 (1): 55. |
| [9] | Lin B, Chen T, Zhang Q, Lu X, Zheng Z, Ding J, et al. FAM83D associates with high tumor recurrence after liver transplantation involving expansion of CD44+ carcinoma stem cells. Oncotarget. 2016 Nov 22; 7 (47): 77495-507. |
| [10] | Liu X, Gao H, Zhang J, Xue D. FAM83D is associated with gender, AJCC stage, overall survival and disease-free survival in hepatocellular carcinoma. Biosci Rep. 2019 May 31; 39 (5). |
| [11] | Liao W, Liu W, Liu X, Yuan Q, Ou Y, Qi Y, et al. Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma. Oncotarget. 2015 Sep 15; 6 (27): 24132-47. |
| [12] | Wang D, Han S, Peng R, Wang X, Yang XX, Yang RJ, et al. FAM83D activates the MEK/ERK signaling pathway and promotes cell proliferation in hepatocellular carcinoma. Biochem Biophys Res Commun. 2015 Mar 6; 458 (2): 313-20. |
| [13] | Hua YQ, Zhang K, Sheng J, Ning ZY, Li Y, Shi WD, et al. Fam83D promotes tumorigenesis and gemcitabine resistance of pancreatic adenocarcinoma through the Wnt/beta-catenin pathway. Life Sci. 2021 Feb 8: 119205. |
| [14] | Yang XX, Ma M, Sang MX, Zhang XY, Zou NY, Zhu SC. Knockdown of FAM83D Enhances Radiosensitivity in Coordination with Irradiation by Inhibiting EMT via the Akt/GSK-3beta/Snail Signaling Pathway in Human Esophageal Cancer Cells. Onco Targets Ther. 2020; 13: 4665-78. |
| [15] | Huang M, Ma X, Shi H, Hu L, Fan Z, Pang L, et al. FAM83D, a microtubule-associated protein, promotes tumor growth and progression of human gastric cancer. Oncotarget. 2017 Sep 26; 8 (43): 74479-93. |
| [16] | Wang F, Zhang S, Wei Y, Chen H, Jiao Z, Li Y. Upregulation of family with sequence similarity 83 member D expression enhances cell proliferation and motility via activation of Wnt/beta-catenin signaling and predicts poor prognosis in gastric cancer. Cancer Manag Res. 2019; 11: 6775-91. |
| [17] | Yan L, Yao J, Qiu J. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D. Biomed Pharmacother. 2017 Dec; 96: 974-81. |
| [18] | Mu Y, Zou H, Chen B, Fan Y, Luo S. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway. Biomed Pharmacother. 2017 Jun; 90: 548-54. |
| [19] | Zhang Q, Yu S, Lok SIS, Wong AST, Jiao Y, Lee LTO. FAM83D promotes ovarian cancer progression and its potential application in diagnosis of invasive ovarian cancer. J Cell Mol Med. 2019 Jul; 23 (7): 4569-81. |
| [20] | Zhu H, Diao S, Lim V, Hu L, Hu J. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway. Acta Biochim Biophys Sin (Shanghai). 2019 May 23; 51 (5): 509-16. |
| [21] | Liu J, Wu Z, Sun R, Nie S, Meng H, Zhong Y, et al. Using mRNAsi to identify prognostic-related genes in endometrial carcinoma based on WGCNA. Life Sci. 2020 Oct 1; 258: 118231. |
| [22] | Uyar DS, Huang YW, Chesnik MA, Doan NB, Mirza SP. Comprehensive serum proteomic analysis in early endometrial cancer. J Proteomics. 2021 Mar 15; 234: 104099. |
| [23] | Perez-Pena J, Alcaraz-Sanabria A, Nieto-Jimenez C, Paez R, Corrales-Sanchez V, Serrano-Oviedo L, et al. Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors. Oncotarget. 2017 Mar 28; 8 (13): 21733-40. |
| [24] | Zhai X, Yang Z, Liu X, Dong Z, Zhou D. Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer. PeerJ. 2020; 8: e9975. |
| [25] | Fei H, Chen S, Xu C. RNA-sequencing and microarray data mining revealing: the aberrantly expressed mRNAs were related with a poor outcome in the triple negative breast cancer patients. Ann Transl Med. 2020 Mar; 8 (6): 363. |
| [26] | Wang Z, Liu Y, Zhang P, Zhang W, Wang W, Curr K, et al. FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7. Oncotarget. 2013 Dec; 4 (12): 2476-86. |
| [27] | Fu Y, Zhou QZ, Zhang XL, Wang ZZ, Wang P. Identification of Hub Genes Using Co-Expression Network Analysis in Breast Cancer as a Tool to Predict Different Stages. Med Sci Monit. 2019 Nov 23; 25: 8873-90. |
| [28] | Cipriano R, Miskimen KL, Bryson BL, Foy CR, Bartel CA, Jackson MW. Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer. Mol Cancer Res. 2014 Aug; 12 (8): 1156-65. |
| [29] | Li Q, Zhou K, Du D, Chen Y, Liu D, Guan X. Dynamic expression of FAM83D in peripheral organs at different ages in mice. Gene Expr Patterns. 2021 Sep; 41: 119199. |
APA Style
Dekang Liu, Xiaowei Guan. (2022). FAM83D and Malignant Tumors: A Brief Literature Review. Biomedical Sciences, 8(2), 53-56. https://doi.org/10.11648/j.bs.20220802.11
ACS Style
Dekang Liu; Xiaowei Guan. FAM83D and Malignant Tumors: A Brief Literature Review. Biomed. Sci. 2022, 8(2), 53-56. doi: 10.11648/j.bs.20220802.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.bs.20220802.11,
author = {Dekang Liu and Xiaowei Guan},
title = {FAM83D and Malignant Tumors: A Brief Literature Review},
journal = {Biomedical Sciences},
volume = {8},
number = {2},
pages = {53-56},
doi = {10.11648/j.bs.20220802.11},
url = {https://doi.org/10.11648/j.bs.20220802.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.bs.20220802.11},
abstract = {Background: FAM83D is a spindle related protein and plays critical roles in mid-plate formation during mitosis. Aberrant FAM83D expression was reported in multiple cancers. Besides, it was observed that FAM83D was capable of promoting the proliferation and migration of normal or cancer cells in several tissues. Objective: we are aiming to update the latest advancement in FAM83D findings, and make a comprehensive review of FAM83D, in order to provide new perspectives for the research of FAM83D in tumors. Methods: Here, we summarized the latest published literatures of FAM83D in recent five years and categorized the research of FAM83D into lung cancer, digestive system cancers and female reproductive cancers. Then, we discussed the relationship of FAM83D and diagnosis, development and prognosis of multiple cancers, as well as the relevant in vitro intracellular underlying mechanisms. Conclusions: Up to now, FAM83D has been investigated in 9 types of cancers and its expression patterns found to tightly related to OS or DFS. Besides, most in vitro studies showed that FAM83D positively regulated cancer cell proliferations and differentiations. Furthermore, researches screened out several downstream targets and intracellular pathways of FAM83D as well as upstream regulatory factors. Prospectively, the biochemistry features of FAM83D protein and its potential as a biomarker of cancer diagnosis or therapy require more independent and rigorous studies.},
year = {2022}
}
TY - JOUR T1 - FAM83D and Malignant Tumors: A Brief Literature Review AU - Dekang Liu AU - Xiaowei Guan Y1 - 2022/04/26 PY - 2022 N1 - https://doi.org/10.11648/j.bs.20220802.11 DO - 10.11648/j.bs.20220802.11 T2 - Biomedical Sciences JF - Biomedical Sciences JO - Biomedical Sciences SP - 53 EP - 56 PB - Science Publishing Group SN - 2575-3932 UR - https://doi.org/10.11648/j.bs.20220802.11 AB - Background: FAM83D is a spindle related protein and plays critical roles in mid-plate formation during mitosis. Aberrant FAM83D expression was reported in multiple cancers. Besides, it was observed that FAM83D was capable of promoting the proliferation and migration of normal or cancer cells in several tissues. Objective: we are aiming to update the latest advancement in FAM83D findings, and make a comprehensive review of FAM83D, in order to provide new perspectives for the research of FAM83D in tumors. Methods: Here, we summarized the latest published literatures of FAM83D in recent five years and categorized the research of FAM83D into lung cancer, digestive system cancers and female reproductive cancers. Then, we discussed the relationship of FAM83D and diagnosis, development and prognosis of multiple cancers, as well as the relevant in vitro intracellular underlying mechanisms. Conclusions: Up to now, FAM83D has been investigated in 9 types of cancers and its expression patterns found to tightly related to OS or DFS. Besides, most in vitro studies showed that FAM83D positively regulated cancer cell proliferations and differentiations. Furthermore, researches screened out several downstream targets and intracellular pathways of FAM83D as well as upstream regulatory factors. Prospectively, the biochemistry features of FAM83D protein and its potential as a biomarker of cancer diagnosis or therapy require more independent and rigorous studies. VL - 8 IS - 2 ER -
Information
Email: